Conspire away podcast full#

That explains why an artist like Bruce Springsteen commands $550M for his song catalog (the biggest deal I found). If a song has been popular for the last 50 years, it will likely stay popular for the next 50.

I've never seen a private business selling for 15X annual revenue. Compared to the multiples that private businesses sell for, that's a ton of money. Older artists want to cash out and secure their estates while demand is high.Ī lot! Hipgnosis reportedly pays about 15 years' worth of royalties upfront.Lots of buyers will attract lots of sellers. Private equity and hedge funds are pouring money into the space.Every time a song gets played, someone gets paid. Services like TikTok and Spotify have created massive demand for music usage.Twenty years after the industry got a gut punch from pirating, music is an awesome business again. Hipgnosis is part of a new breed of companies gobbling up music rights. They sold their song catalogs to Hipgnosis, the $2B powerhouse that's transforming the music biz. They did it the same way - not with concerts or endorsements. Practice choosing the critic you want to listen to, and discarding the ones you don't want to.

Conspire away podcast full#

The internet, and the real world, is full of trolls. There is not a single human on the planet who does not have some critic pulling them down.īut what you must remember is that if you don't value someone enough to go to them for positive upliftment, then you should definitely not value their negativity. No matter who you are, what you do, you will have random people throwing criticism your way. What is the lesson here? If Justin and Pinkfong (and millions of other creators like them) decided to listen to every critic, they'd never be who they are.īecause simply put, you don't need to listen to the criticism of people who you don't also take advice from. Justin Bieber has 30Million+ dislikes on his videos. His song, Baby, is ALSO in the most Liked AND most disliked videos of all time. Similarly, in 2010, a young artist created the most disliked music video on YouTube at the time. The Baby Shark video features BOTH on the most liked AND the most disliked video on YouTube. And a staggering 12Billion views in 6 years. Today, powered by the same hated song, they are worth $1B+, with ~100M YT subscribers.īecause despite the 15M+ dislikes, the song also generated 39M+ likes. Pinkfong, a South Korean company, created one of the most disliked video on YouTube ever - 15M+ dislikes and counting. #AWSHealthPod #HealthInnovation #HealthcareStartups #HealthcarePodcasts #Podcast Learn more about how AWS enables healthcare and life science startups to grow & thrive ( ) and how healthcare & life sciences industry leaders leverage the cloud to accelerate health innovation ( ) Listen & subscribe wherever you get your podcasts! ✅ Fireside chat with Rainer Strohmenger and Regina Hodits, Managing Partners at Wellington Partners detailing their investment approach, how they support startups, and pragmatic advice for founders. Sarkar (Principal, Healthcare & Life Sciences, Amazon Web Services (AWS)) covering Europe & America’s complementary roles accelerating healthcare innovation. Law Law (Chief Business Officer, Exscientia), Edward Kliphuis (Partner, Sofinnova Partners) and Amrita Sarkar, Ph.D. ✅ Interview with Dana Gourevich (Chief Technology Officer, Israel Innovation Authority) showcasing how Israel uses public/private partnerships to match leading talent from its universities to life sciences research challenges, highlighting AION Labs as an example. As the industry undergoes digital transformation via the adoption of cloud, high performance computing and machine learning, new opportunities for investment and collaboration are emerging. Tune in for the latest episode of the Amazon Web Services (AWS) Health Innovation podcast, recorded live at the “ - Trends from Accross the Pond” symposium AWS co-hosted with Wellington Partners at JPM.Įurope and Israel are hotbeds of healthcare & life science innovation, with talent from top-class research institutes, leading pharmaceutical companies and VC’s all playing on the global stage.